Clinicopathologic features of patients with hepatocellular carcinoma seropositive for α‐fetoprotein‐L3 and seronegative for des‐γ‐carboxy prothrombin in comparison with those seropositive for des‐γ‐carboxy prothrombin alone
Hiroaki Okuda(Tokyo Women's Medical University), Masayuki Nakano(Nihon University), Kazuko Takatsu(Tokyo Women's Medical University), Naoaki Hayashi(Kyoto University), Toshimi Nakanishi(Tokyo Women's Medical University), Masakazu Yamamoto(Tokyo Women's Medical University), Ken Takasaki(Tokyo Women's Medical University), Akiko Saito(Tokyo Women's Medical University)
Cited by 53
Related Papers
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging
|Radiology|2011|354
cHCC‐CCA
|Hepatology|2018|333
Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma.A study of 57 autopsy-proven cases
|Cancer|1977|262
Perivenular Fibrosis in Alcoholic Liver Injury: Ultrastructure and Histologic Progression
|Gastroenterology|1982|249